Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194025 · ClinicalTrials.gov registry record · Phase 4
Valproate in Late Life Schizophrenia
A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00194025 is a Phase 4 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT00194025, a Phase 4 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to analyze the effectiveness and tolerability of a medication, valproate ( Depakote and Depakote ER), in individuals age 50 years and older who have schizophrenia.
Interventions
- DRUG Valproate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194025
The ClinicalTrials.gov registry entry for NCT00194025 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valproate is the first listed.
NCT00194025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194025 about?
NCT00194025 is a clinical study titled "Valproate in Late Life Schizophrenia". The purpose of this research study is to analyze the effectiveness and tolerability of a medication, valproate ( Depakote and Depakote ER), in individuals age 50 years and older who have schizophrenia.
What is the current status of trial NCT00194025?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-11. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00194025?
The interventions under investigation include: Valproate (DRUG).
Who is sponsoring clinical trial NCT00194025?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.